Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis
Objective. Soluble CD206 (sCD206) is considered a macrophage activation marker, and a previous study proved it as a potential biomarker to predict the severity of anti-melanoma differentiation-associated gene 5- (anti-MDA-5-) positive dermatomyositis- (DM-) associated interstitial lung disease (ILD)...
Saved in:
| Main Authors: | Ya-Wen Shen, Ya-Mei Zhang, Zhen-Guo Huang, Guo-Chun Wang, Qing-Lin Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2020/7948095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
by: Darija Logvinova, et al.
Published: (2024-11-01) -
A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
by: Shinji Sato, et al.
Published: (2014-01-01) -
Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
by: Yuanyuan Niu, et al.
Published: (2024-10-01) -
Soluble CD206 and CD163 as novel prognostic biomarkers in adult acute myeloid leukemia
by: Haifa A. Al-Matari, et al.
Published: (2024-11-01) -
Transcriptomic characterization of human pancreatic CD206- and CD206 + macrophages
by: Alexander Jonsson, et al.
Published: (2025-04-01)